Schedule 13D ownership disclosure

TRINITY BIOTECH INVT LTD

Class A Ordinary Shares, $0.0001 par value per share · CUSIP: 896438504

Event date: 2025-12-22

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Perceptive Advisors LLCReported CIK 0001224962

    Shares: 1,498,858,251 · Class: 9.9%

  • Perceptive Credit Advisors LLCReported CIK 0001877081

    Shares: 1,498,858,251 · Class: 9.9%

  • Joseph EdelmanReported CIK 0001164426

    Shares: 1,498,858,251 · Class: 9.9%

  • Perceptive Credit Holdings II, L.P.

    Shares: 278,809,708 · Class: 9.9%

  • Perceptive Credit Holdings III, L.P.Reported CIK 0001877078

    Shares: 1,220,048,543 · Class: 9.9%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-25-331083
Form type
SCHEDULE 13D/A
Filer
PERCEPTIVE ADVISORS LLC
CIK
CIK 1224962
Filed
Dec 23, 2025
Reporting period
Dec 22, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub